Medindia

X

Benlysta Will Garner Sales of More Than $500 Million in 2018 in the Systemic Lupus Erythematosus Drug Market

Monday, February 1, 2010 General News J E 4
Advertisement
Following Its Expected Approval, Benlysta Will Be the First Agent to Launch for the Disease in More Than 40 Years, According to New Findings from Decision Resources

Decision Resources

Decision Resources, Inc.

Gisselle Morales

Christopher Comfort

781-296-2691

781-296-2597

gmorales@dresources.com

ccomfort@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Inverness Medical Innovations to Present at the UB...
S
Repligen to Present at the BIO CEO & Investor Conf...